Dosidal · Switzerland

Rifampicin Labatec i.v., poudre pour solution pour perfusion

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65101 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65101
atc: J04AB02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2014-05-28
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J04AB02
authorisation_number: 65101
form: PULVI
holder: Labatec Pharma SA
holder_partner_nr: 1000310
it_number: 08.02.1.
name: Rifampicin Labatec i.v., poudre pour solution pour perfusion
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
UItQAfcOfajQHmO1MD7q8Rs1VouRxd9xGuIY8LkGw6_t-3DapWZQeMcGNO85tn-t6zja3TvTKN2bTNLSavQkzQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65101 · Related records in other markets · Dosidal